Immunotope Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 3

Immunotope General Information

Description

Developer of immunotherapy products created for the treatment and prevention of cancer and chronic viral infections. The company's immunotherapy platform provides the ideal combination of technologies for successful immunotherapy, use the exquisite sensitivity and specificity of the immune system for early detection of cancer, provide innovative tools and services for collaborative development of novel drug and diagnostic products, enabling patients with effective treatments that destroy tumors and prevent metastasis.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • The Pennsylvania Biotechnology Center
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (251)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • The Pennsylvania Biotechnology Center
  • 3805 Old Easton Road
  • Doylestown, PA 18902
  • United States
+1 (251)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunotope Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Immunotope‘s full profile, request access.

Request a free trial

Immunotope Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunotherapy products created for the treatment and prevention of cancer and chronic viral infections. The
Drug Discovery
Doylestown, PA

Seal Beach, CA
 

Cambridge, MA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunotope Competitors (49)

One of Immunotope’s 49 competitors is Dendreon, a Formerly VC-backed company based in Seal Beach, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dendreon Formerly VC-backed Seal Beach, CA
AnTolRx Formerly VC-backed Cambridge, MA
Virometix Venture Capital-Backed Schlieren, Switzerland
Xenetic Biosciences Corporation Framingham, MA
Amal Therapeutics Formerly VC-backed Geneva, Switzerland
You’re viewing 5 of 49 competitors. Get the full list »

Immunotope Patents

Immunotope Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020051566-A1 Vaccines with enhanced immune response and methods for their preparation Inactive 07-Sep-2018
US-20170119869-A1 Dengue virus specific multiple hla binding t cell epitopes for the use of universal vaccine development Active 13-May-2014
WO-2015175361-A1 Dengue virus specific multiple hla binding t cell epitopes for the use of universal vaccine development Inactive 13-May-2014
US-20160361410-A1 Mhc class i associated peptides for prevention and treatment of hepatitis b virus infection Active 28-Feb-2014
WO-2015130488-A2 Mhc class i associated peptides for prevention and treatment of hepatitis b virus infection Inactive 28-Feb-2014 A61K39/12
To view Immunotope’s complete patent history, request access »

Immunotope FAQs

  • When was Immunotope founded?

    Immunotope was founded in 2002.

  • Where is Immunotope headquartered?

    Immunotope is headquartered in Doylestown, PA.

  • What industry is Immunotope in?

    Immunotope’s primary industry is Drug Discovery.

  • Is Immunotope a private or public company?

    Immunotope is a Private company.

  • What is Immunotope’s current revenue?

    The current revenue for Immunotope is .

  • Who are Immunotope’s competitors?

    Dendreon, AnTolRx, Virometix, Xenetic Biosciences, and Amal Therapeutics are some of the 49 competitors of Immunotope.

  • When was Immunotope acquired?

    Immunotope was acquired on 16-Jul-2010.

  • Who acquired Immunotope?

    Immunotope was acquired by IMV (Canada).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process